95 related articles for article (PubMed ID: 18364671)
1. Why should we avoid the use of rosiglitazone?
Mikhail N
South Med J; 2008 Mar; 101(3):329-31. PubMed ID: 18364671
[No Abstract] [Full Text] [Related]
2. Comments on 'Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death'.
Carpenter J; Rücker G; Schwarzer G
Stat Med; 2008 Aug; 27(19):3910-2; author reply 3912-4. PubMed ID: 18069734
[No Abstract] [Full Text] [Related]
3. The rosiglitazone meta-analysis.
McCullough PA; Lepor NE
Rev Cardiovasc Med; 2007; 8(2):123-6. PubMed ID: 17603430
[No Abstract] [Full Text] [Related]
4. Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death.
Shuster JJ; Jones LS; Salmon DA
Stat Med; 2007 Oct; 26(24):4375-85. PubMed ID: 17768699
[TBL] [Abstract][Full Text] [Related]
5. Drug safety. Heart attack risk overshadows a popular diabetes therapy.
Couzin J
Science; 2007 Jun; 316(5831):1550-1. PubMed ID: 17569830
[No Abstract] [Full Text] [Related]
6. Rosiglitazone and cardiovascular risk.
Diamond GA; Kaul S
N Engl J Med; 2007 Aug; 357(9):938-9; author reply 939-40. PubMed ID: 17806135
[No Abstract] [Full Text] [Related]
7. Rosiglitazone and cardiovascular disease: a cardiologist's perspective.
Marx N
Diab Vasc Dis Res; 2007 Jun; 4(2):80-1. PubMed ID: 17654439
[No Abstract] [Full Text] [Related]
8. Rosiglitazone and cardiovascular disease: a diabetologist's perspective.
Grant PJ
Diab Vasc Dis Res; 2007 Jun; 4(2):75-6. PubMed ID: 17654437
[No Abstract] [Full Text] [Related]
9. The Avandia debate.
Bloomgarden ZT
Diabetes Care; 2007 Sep; 30(9):2401-8. PubMed ID: 17726191
[No Abstract] [Full Text] [Related]
10. Analytical issues regarding rosiglitazone meta-analysis.
Claggett B; Wei LJ
Arch Intern Med; 2011 Jan; 171(2):179-80; author reply 180. PubMed ID: 21263111
[No Abstract] [Full Text] [Related]
11. Rosiglitazone, marketing, and medical science.
Moynihan R
BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091
[No Abstract] [Full Text] [Related]
12. Revisiting the rosiglitazone story--lessons learned.
Rosen CJ
N Engl J Med; 2010 Aug; 363(9):803-6. PubMed ID: 20660395
[No Abstract] [Full Text] [Related]
13. Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials.
Mannucci E; Monami M; Di Bari M; Lamanna C; Gori F; Gensini GF; Marchionni N
Int J Cardiol; 2010 Aug; 143(2):135-40. PubMed ID: 19328563
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone: a thunderstorm from scarce and fragile data.
Mulrow CD; Cornell J; Localio AR
Ann Intern Med; 2007 Oct; 147(8):585-7. PubMed ID: 17938398
[No Abstract] [Full Text] [Related]
15. Rosiglitazone: failure of oversight or demons imagined?
Susman J
J Fam Pract; 2007 Sep; 56(9):696, 703. PubMed ID: 17764640
[No Abstract] [Full Text] [Related]
16. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
Ziyadeh N; McAfee AT; Koro C; Landon J; Arnold Chan K
Clin Ther; 2009 Nov; 31(11):2665-77. PubMed ID: 20110009
[TBL] [Abstract][Full Text] [Related]
17. FDA eases restrictions on the glucose-lowering drug rosiglitazone.
Mitka M
JAMA; 2013 Dec; 310(24):2604. PubMed ID: 24368444
[No Abstract] [Full Text] [Related]
18. Rosiglitazone and cardiovascular risk.
Mannucci E; Monami M; Marchionni N
N Engl J Med; 2007 Aug; 357(9):938; author reply 939-40. PubMed ID: 17806136
[No Abstract] [Full Text] [Related]
19. A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14,237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone.
Cobitz A; Zambanini A; Sowell M; Heise M; Louridas B; McMorn S; Semigran M; Koch G
Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):769-81. PubMed ID: 18613278
[TBL] [Abstract][Full Text] [Related]
20. FDA panel advises easing restrictions on rosiglitazone.
Tucker ME
BMJ; 2013 Jun; 346():f3769. PubMed ID: 23752055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
